Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
9.24
-0.26 (-2.74%)
Jan 17, 2025, 4:00 PM EST - Market closed
Mineralys Therapeutics Employees
Mineralys Therapeutics had 28 employees as of December 31, 2023. The number of employees increased by 16 or 133.33% compared to the previous year.
Employees
28
Change (1Y)
16
Growth (1Y)
133.33%
Revenue / Employee
n/a
Profits / Employee
-$5,473,321
Market Cap
459.86M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 28 | 16 | 133.33% |
| Dec 31, 2022 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
MLYS News
- 1 day ago - Mineralys Therapeutics: Lorundrostat Is Worth A Shot In 2025 For Hypertension - Seeking Alpha
- 2 months ago - Mineralys Therapeutics, Inc. (MLYS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Mineralys Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - Mineralys Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Mineralys Therapeutics to Announce Third Quarter 2024 Financial Results and Host Conference Call on Monday, November 11, 2024 - GlobeNewsWire
- 3 months ago - Mineralys Therapeutics Inc Is Being Investigated For Securities Law Violations And Shareholders With Losses Are Urged To Contact The Schall Law Firm - Accesswire
- 3 months ago - The Schall Law Firm Invites Investors To Join An Inquiry Into Mineralys Therapeutics, Inc. For Securities Fraud - Accesswire
- 3 months ago - Mineralys Therapeutics Inc Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm - Accesswire